Wuling Liu
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 10%
- Enterobacteriaceae and Cronobacter Research
Papers in
-
- Retinoids in leukemia and cellular processes 4
- Cell death mechanisms and regulation 3
- Kruppel-like factors research 3
- Phytochemical compounds biological activities 3
-
- Acute Myeloid Leukemia Research 3
- Co-authors
- Babu Gajendran (27 shared papers)Yaacov Ben‐David (25 shared papers)Eldad Zacksenhaus (19 shared papers)Jian–Hua Liu (3 shared papers)Zhenling Zeng (3 shared papers)Yanmei Li (10 shared papers)Luchao Lv (2 shared papers)Dandan He (2 shared papers)
In The Last Decade
Wuling Liu
34 papers receiving 344 citations
Peers
Comparison fields: 5 of 70
- Molecular Medicine 120
- Endocrinology 52
- Pollution 38
- Hematology 36
- Toxicology 9
Countries citing papers authored by Wuling Liu
This map shows the geographic impact of Wuling Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wuling Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wuling Liu more than expected).
Fields of papers citing papers by Wuling Liu
This network shows the impact of papers produced by Wuling Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wuling Liu. The network helps show where Wuling Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wuling Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 80 | |
| 2 | 2018 | 26 | |
| 3 | 2019 | 26 | |
| 4 | 2015 | 23 | |
| 5 | 2017 | 20 | |
| 6 | 2019 | 18 | |
| 7 | 2021 | 18 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 11 | |
| 10 | 2020 | 10 | |
| 11 | 2020 | 9 | |
| 12 | 2022 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2021 | 8 | |
| 15 | 2021 | 6 | |
| 16 | 2019 | 6 | |
| 17 | 2023 | 5 | |
| 18 | 2022 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2022 | 5 |
About Wuling Liu
Wuling Liu is a scholar working on Molecular Biology, Hematology, Immunology, Cancer Research and Pathology and Forensic Medicine, having authored 36 papers that have together received 346 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (4 papers), Acute Myeloid Leukemia Research (3 papers), Cancer Mechanisms and Therapy (3 papers), Cell death mechanisms and regulation (3 papers), Autophagy in Disease and Therapy (3 papers), Kruppel-like factors research (3 papers), Phytochemical compounds biological activities (3 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Molecular Medicine (120 citations), Endocrinology (52 citations), Pollution (38 citations), Hematology (36 citations) and Toxicology (9 citations). Wuling Liu has collaborated with scholars based in China, Canada and India. Frequent co-authors include Babu Gajendran, Yaacov Ben‐David, Eldad Zacksenhaus, Jian–Hua Liu, Zhenling Zeng, Yanmei Li, Luchao Lv, Dandan He, Xiaojie Chen and Klarke M. Sample. Their work appears in journals such as BMC Cancer, Biomedicine & Pharmacotherapy, Medical Oncology, Frontiers in Microbiology and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.